慢性肾脏病早期发现:低收入、中等收入和高收入国家的启示
综述比较了人群筛查与病例发现两种CKD早期检测策略。数据显示人群筛查获益不确定且可能存在危害,资源利用效率低,即使在高收入国家也不明智;而病例发现在已知肾脏风险因素(糖尿病、高血压、心血管疾病)人群中吸引力更高,高、中、低收入国家均适用。检测新病例最容易,真正挑战是确保慢性病获得长期适当管理。
要点
- 人群筛查CKD获益不确定,存在潜在危害,资源利用效率低
- 病例发现在已知肾脏风险因素人群中吸引力更高,各国均适用
- 早期检测的真正挑战是确保慢性病获得长期适当管理
核心结论
- 人群筛查CKD的获益不确定,存在潜在危害,即使在高收入国家也非明智的资源利用。
- 病例发现在已知肾脏风险因素人群中吸引力更高,高收入及中低收入国家均适用。
- 早期检测的真正挑战是确保慢性病获得长期适当管理,而非仅仅发现新病例。
研究设计与样本
- 综述比较人群筛查与病例发现两种CKD早期检测策略的获益、危害和机会成本。
主要发现
- 人群筛查CKD获益不确定,存在潜在危害,资源利用效率低,中低收入国家机会成本高。
- 病例发现在糖尿病、高血压和心血管疾病患者中CKD患病率更高,且这些患者已有较高肾脏检测使用率,增加了其吸引力。
临床怎么用
- 在高、中低收入国家,对已知肾脏风险因素(糖尿病、高血压、心血管疾病)人群考虑病例发现而非人群筛查。
- 早期检测后需确保慢性病获得长期适当管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CKD is common, costly, and associated with adverse health outcomes. Because inexpensive treatments can slow the rate of kidney function loss, and because CKD is asymptomatic until its later stages, the idea of early detection of CKD to improve outcomes ignites enthusiasm, especially in low- and middle-income countries where renal replacement is often unavailable or unaffordable. Available data and prior experience suggest that the benefits of population-based screening for CKD are uncertain; that there is potential for harms; that screening is not a wise use of resources, even in high-income countries; and that screening has substantial opportunity costs in low- and middle-income countries that offset its hypothesized benefits. In contrast, some of the factors that diminish the value of population-based screening (such as markedly higher prevalence of CKD in people with diabetes, hypertension, and cardiovascular disease, as well as high preexisting use of kidney testing in such patients) substantially increase the appeal of searching for CKD in people with known kidney risk factors (case finding) in high-income countries as well as in low- and middle-income countries. For both screening and case finding, detection of new cases is the easiest component; the real challenge is ensuring appropriate management for a chronic disease, usually for years or even decades. This review compares and contrasts the benefits, harms, and opportunity costs associated with these two approaches to early detection of CKD. We also suggest criteria (discussed separately for high-income countries and for low- and middle-income countries) to use in assessing when countries should consider case finding versus when they should consider foregoing systematic attempts at early detection and focus on management of known cases.
引用
- Tonelli M, Dickinson JA. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries. J Am Soc Nephrol. 2020. PMID: 32839279. doi:10.1681/ASN.2020030277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。